mibefradil has been researched along with naltrindole benzofuran in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chubanov, V; Ferioli, S; Gudermann, T; Hofmann, T; Schäfer, S; Zierler, S | 1 |
| DenBesten, P; Földes, A; Juhász, V; Kádár, K; Kató, E; Köles, L; Löchli, H; Rácz, R; Steward, MC; Varga, G; Zhang, Y; Zsembery, Á | 1 |
2 other study(ies) available for mibefradil and naltrindole benzofuran
| Article | Year |
|---|---|
Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.
Topics: 1-Naphthylamine; Animals; Calcium; Calcium Channel Blockers; HEK293 Cells; Humans; Magnesium; Mibefradil; Mice; Naltrexone; TRPM Cation Channels | 2016 |
TRPM7-Mediated Calcium Transport in HAT-7 Ameloblasts.
Topics: Ameloblasts; Anilides; Animals; Calcium; Cell Line; Humans; Hydrogen-Ion Concentration; Incisor; Ion Channel Gating; Ion Transport; Mibefradil; Mice; Models, Biological; Naltrexone; Rats; Thiadiazoles; TRPM Cation Channels | 2021 |